PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
08-Jan-2026 Lonza’s Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next‑Generation Bispecific ADCs Lonza’s Synaffix
08-Jan-2026 Nucleome Therapeutics nominates first preclinical development candidate Nucleome Therapeutics
08-Jan-2026 STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications STORM Therapeutics
08-Jan-2026 Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines NanoSyrinx
08-Jan-2026 NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s NRG Therapeutics
08-Jan-2026 EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome EnteroBiotix
08-Jan-2026 Advanced Therapies Week 2026: Phacilitate Unites CGT Community for New Era Defined by Innovation and Collaboration Advanced Therapies
07-Jan-2026 New Annex 1 Sterile Facility Eramol
06-Jan-2026 Research award will accelerate research to map brain electrical circuits University of Nottingham
06-Jan-2026 LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington’s Disease LoQus23 Therapeutics
06-Jan-2026 HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma HUTCHMED
06-Jan-2026 Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging Biotium
06-Jan-2026 Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation Acesion Pharma
06-Jan-2026 MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy* GSK
05-Jan-2026 STEMart Enhances Medical Device Safety Testing with New In Vitro Micronucleus Test Service STEMart
05-Jan-2026 CD Bioparticles Launches Comprehensive Animal mRNA Vaccine Solutions to Support Veterinary Research CD Bioparticles
05-Jan-2026 CD Bioparticles Launches Additive Powders to Drive Innovation in 3D Printing and Advanced Manufacturing CD Bioparticles
04-Jan-2026 Creative Diagnostics Launches New Line of Subcellular Fractions for In Vitro Metabolism Studies Creative Diagnostics
04-Jan-2026 Creative Diagnostics Introduces Advanced Hepatitis Virus Animal Models to Accelerate HBV Drug and Vaccine Development Creative Diagnostics
04-Jan-2026 Creative Diagnostics Launches New ELISA Kit for the Reliable Detection of JCV IgG Antibodies Creative Diagnostics